Try our Advanced Search for more refined results

November 17, 2014

Mallinckrodt Inc. v. United States Food and Drug Administration et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 12, 2015

    FDA Wins Toss Of Mallinckrodt Suit Over Equivalence Rating

    A Maryland federal judge has axed Mallinckrodt Inc.'s lawsuit challenging a change to its therapeutic equivalence rating for a generic version of Janssen Pharmaceuticals Inc.'s Concerta, finding no procedural or constitutional violations by the U.S. Food and Drug Administration in a ruling unsealed Wednesday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login